Kurma’s Munich move

How French VC Kurma plans to turn German research into biotechs

Kurma Partners has opened a Munich office to spin out German academic science into biotechs in a bid to apply its company creation model to bridge the country’s venture capital gap for translating compelling research.

The new office reflects Kurma's shift to a pan-European incubation strategy with its Biofund III, for which

Read the full 512 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE